An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series.
An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series.
复制标题
对大型耻骨后前列腺切除术系列中手术切缘阳性发生率降低的评估。
DOI:
10.1097/01.ju.0000098604.09395.27
复制
发表时间:
2004
期刊:
影响因子:
--
通讯作者:
Walsh,PatrickC
中科院分区:
文献类型:
--
作者:
Han,Misop;Partin,AlanW;Chan,DavidY;Walsh,PatrickC
PurposePositive surgical margins adversely affect biochemical recurrence-free survival after radical retropubic prostatectomy (RRP) for prostate cancer. We retrospectively reviewed a large series of men who underwent RRP at a single academic university urology program to define the change in the incidence of organ confined (OC) disease and positive surgical margin (SM+) during the last 2 decades.Materials and MethodsBetween 1982 and 2001, 9,035 men underwent RRP for clinically localized prostate cancer (T1 to T3a) at a single institution. We compared the incidences of OC disease and SM+ in this population.ResultsAn increasing proportion of men presented with OC disease over time. The incidence of SM+ in the overall RRP population decreased dramatically over time. However, in men with nonorgan confined disease (pT3), the proportion with SM+ was stable and consistently elevated (22.7% to 27.8%), after the initial decrease from the early 1980s (53%).ConclusionsWidespread early detection programs for prostate cancer resulted in a downward stage migration in men presenting with clinically localized prostate cancer at our institution during the last 2 decades. The decrease in the percentage of men with SM+ was due to the increasing number of men with organ confined disease. These results imply that the decrease in surgical margin rates in the overall RRP population is most likely due to stage migration and improved patient selection, rather than major improvements in surgical technique. The stable percentage of SM+ among men with pT3 disease dictates the need for continued evaluation of surgical technique and the need for effective adjuvant therapy.
登录
查看更多内容
影响因子:
6.6
作者:
Patrick C. Walsh;J. I. Epstein;Franklin C. Lowe
通讯作者:
Franklin C. Lowe
影响因子:
6.6
作者:
W. Pitts
通讯作者:
W. Pitts
影响因子:
1.9
作者:
R. Donnell
通讯作者:
R. Donnell
DOI:
--
发表时间:
1999
期刊:
Metabolism: Clinical and Experimental
影响因子:
--
作者:
K. Mahlbacher;A. Sicuro;H. Gerber;H. Hulter;R. Krapf
通讯作者:
R. Krapf
DOI:
--
发表时间:
2002
期刊:
The Prostate
影响因子:
--
作者:
A. Berger;H. Volgger;H. Rogatsch;D. Strohmeyer;H. Steiner;H. Klocker;G. Bartsch;W. Horninger
通讯作者:
W. Horninger